Related Experiment Video
Updated: May 9, 2025

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune
Santosh Timilsina1, Jian Yu Huang1, Nourhan Abdelfattah2
1Greehey Children's Cancer Research Institute, San Antonio, TX, USA.
Abstract:
The interplay between tumor cells and the microenvironment significantly influences cancer progression. Here, we report a significant role of the transcription factor FOXM1 in shaping the tumor immune landscape. Single-cell sequencing reveals that tumor-intrinsic FOXM1 creates an immune-suppressive tumor microenvironment by inhibiting expression of stress ligands (including ULBP1) on cancer cells, thereby blocking NKG2D-NKG2DL interactions critical for priming natural killer- and T cell-mediated cytotoxicity of cancer cells. FOXM1 suppresses ULBP1 expression by epigenetically silencing the DNA-sensing protein STING using a DNMT1-UHRF1 complex, which in turn inhibits the unfolded protein response protein CHOP from activating ULBP1. Importantly, cancer patients with higher levels of FOXM1 and DNMT1, and lower levels of STING and ULBP1, have worse survival and are less responsive to immunotherapy. Collectively, our findings provide key insight into how a tumor-intrinsic transcription factor epigenetically shapes the tumor immune microenvironment, with strong implications for refining existing and designing new cancer immunotherapies.
Insights
Transcription factor FOXM1 suppresses anti-tumor immunity by epigenetically silencing STING, leading to poor survival and immunotherapy response in cancer patients. This reveals a key mechanism in shaping the tumor immune microenvironment.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Tumor microenvironment and cancer cell interactions critically impact cancer progression.
- Transcription factors play a role in modulating the tumor immune landscape.
Purpose of the Study:
- To investigate the role of transcription factor FOXM1 in shaping the tumor immune microenvironment.
- To elucidate the molecular mechanisms by which FOXM1 influences anti-tumor immunity.
Main Methods:
- Single-cell sequencing to analyze tumor-intrinsic gene expression.
- Epigenetic analysis to understand gene silencing mechanisms.
- Correlation of gene expression with patient survival and immunotherapy response.
Main Results:
- Tumor-intrinsic FOXM1 suppresses immune responses by inhibiting stress ligand ULBP1 expression on cancer cells.
- FOXM1 epigenetically silences STING via a DNMT1-UHRF1 complex, blocking CHOP-mediated ULBP1 activation.
- High FOXM1/DNMT1 and low STING/ULBP1 correlate with worse patient survival and immunotherapy resistance.
Conclusions:
- FOXM1 epigenetically reprograms the tumor immune microenvironment towards immune suppression.
- Targeting the FOXM1-STING-ULBP1 axis may enhance cancer immunotherapy efficacy.
- Understanding this mechanism offers new strategies for cancer treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Psychoneuroimmunology: Diabetes and Cancer